The medtech company with a nose for business
Neurent Medical, the Galway start-up developing a treatment device for nasal inflammation, will begin clinical trials in the US next month on foot of a €9.3 million funding round closed 12 months ago.
Neurent’s co-founder and chief executive Brian Shields said the Series A round, led by Fountain Healthcare Partners, had allowed the company to expedite commercialisation plans.
“We’ll start clinical trials at a tier-one academic centre in Chicago in July. To be ...